Cardiology Letters 2022, 31(1):10-22
Current treatment trends of the non-ST-segment elevation acute coronary syndrome in the Slovak Republic: Analysis of the SLOVAKS-2 2020 register
- 1 Stredoslovenský ústav srdcových a cievnych chorôb a. s., Banská Bystrica, Slovenská republika
Introduction: The SLOVAKS register collects and analyses data on patients with non-ST elevation acute coronary syndrome (NSTE-ACS) in the Slovak Republic.
Objective: Collection, analysis, and evaluation of NSTE-ACS patients' data.
Methodology: Electronic reports from NSTE-ACS inpatients were collected during October and November 2020. Representative demographic and anamnestic variables, risk profiles, diagnostic and therapeutic management (conservative and invasive), and subsequent coronary revascularization were evaluated. Data for the whole cohort were evaluated; some analyses were also conducted with a focus on diabetes mellitus and gender.
Results: From the study period, 714 NSTE-ACS reports were analysed, including 478 men (mean age 65.1±11.5 years) and 236 women (mean age 69.1±11.2 years). Unstable angina pectoris (UAP) was diagnosed in 201 patients and non-ST segment elevation myocardial infarction (NSTEMI) in 489 patients. UAP and NSTEMI patients showed high rates of hypertension (88.1% and 89.6%, respectively), hyperlipoproteinemia (76.1% and 68.7%, respectively) and diabetes mellitus (36.8% and 35.2%, respectively). Complex pharmacotherapy (dual antiplatelet therapy, beta-blockers, statins, ACE inhibitors/sartans) was administered according to current recommendations. 86.5% of NSTEMI patients and 73.1% of UAP patients underwent invasive diagnostics. Interventional treatment was performed in 51.3% of NSTEMI patients and 45.3% of UAP patients. Surgical revascularization was performed in 8% of NSTEACS patients. Patients were transferred for invasive diagnostics in 4.8±4.0 days for men and 5.8±4.4 days for women with NSTE-ACS. There was a tendency towards less frequent revascularization in women than in men.
Conclusion: The SLOVAKS-2 2020 register results confirmed the use of complex pharmacotherapy in NSTE-ACS patients according to guidelines. Compared to previous SLOVAKS register analyses, there was an increased number of patients indicated for invasive diagnostics (and subsequent revascularization), but these patients were transferred late to the relevant cardio entre. Fig. 3, Tab. 9, Ref. 17, Online full text (Free, PDF), www. cardiologyletters.sk
Keywords: SLOVAKS register; acute coronary syndromes; UAP, STEMI; pharmacotherapy; invasive diagnostics
Published: January 1, 2022 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- jamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e526-e528. mirat E, Simon T, Cayla G, et al. Changes in patients characteristics, management, and 6-moth outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015. Circulation 2017;136:1908-1919. let JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021;42:1289-1367. denčan M, Baráková A, Hliva P, et al. Slovenský register akútnych koronárnych syndrómov (SLOVAKS)-analýza údajov z roku 2007. Cardiol 2008;17:179-190. ář F, Studenčan M, Hricák V, et al. Manažment pacientov s akútnym koronárnym syndrómom bez elevácií segmentov ST. Analýza údajov registra SLOVAKS z roku 2008. Cardiology sk 2010;19:181-191. ář F, Studenčan M, Hricák V, et al. Súčasný stav manažmentu pacientov s NSTE-AKS v Slovenskej republike. Analýza výsledkov registra SLOVAKS-2 z roku 2011. Cardiology Lett. 2014;23:115-125. ář F, Studenčan M, Alberty R, et al. Indikujeme adekvátne invazívnu diagnostiku u pacientov s NSTE-AKS? Analýza výsledkov registra SLOVAKS-2 z roku 2015. Cardiology Lett. 2017;26:69-82. nger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163:2345-2353. n YH, Huang SS, Lin SJ. TIMI and GRACE risk scores predict both short-term and long-therm outcomes in Chinese patients with acute myocardial infarction Acta Cardiol Sin 2018;34:412. le KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004;291:2727-2733. KA, Eagle KA, Gore JM, et al. The Global registry of acute coronary events, 1991 to 2009-Grace. Heart 2010;96:10951101. talescot G, Dallongeville J, Van Belle E, et al. STEMI nad NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by ESC/ACC definition (the OPERA registry). Eur Heart J 2007;28:1409-1417. mer K, Wallentin L, Lindhgen L, et al. Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014. Eur Heart J 2018;39:3766-3776. anus D, Gore J, Yarzebski J, et al. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Amer J Cardiol 23011;124:40-47. chlin T, Twerenbold R, Reiter M, et al. Introduction of highsensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med 2012;125:1205-1213. h ASV, Anand A, Strachan FE, et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomized controlled trial. Lancet 2018;392:9019-928. ry AA, Kumbhani DJ, Rassi AN, et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006;48:1319-1325.